Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Ding

Showing results (691-700 of 716) with videos related to

Pageof 72
Sort By:
Journal of Medicinal Chemistry|June 8, 2026
Structure-Based Design and Optimization of Novel, Potent and Selective Covalent FGFR2/3 Inhibitors with a Tricyclic CoreXuzhi Lu, Zhaodi Tian, Xueqiang Li, et al.
Nature Communications|November 6, 2021
Aerosol-boundary-layer-monsoon interactions amplify semi-direct effect of biomass smoke on low cloud formation in Southeast AsiaKe Ding, Xin Huang, Aijun Ding, et al.
Diabetes|January 22, 2017
Visualization and Quantification of Browning Using a Ucp1-2A-Luciferase Knock-in Mouse ModelLiufeng Mao, Baoming Nie, Tao Nie, et al.
Cancer Science|December 2, 2021
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivoYingqiang Liu, Mengzhen Lai, Shan Li, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|April 3, 2012
Multi-central clinical research into treating 80 cases of chronic thrombocytopenia with qi-supplementing and yin-nourishing therapy and western medicineYu-Hong Zhou, Ke-Ming Wei, Lv-Yuan He, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibitionSanjeev Shangary, Dongguang Qin, Donna McEachern, et al.
Cell Reports. Medicine|March 25, 2026
Targeting the ferritinophagy-lysosome axis as a therapeutic vulnerability in gastroenteropancreatic neuroendocrine tumorsYizhi Cao, Caleb Cheng, Yitong Yin, et al.
Signal Transduction and Targeted Therapy|April 20, 2026
Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trialHong Wang, Qingyuan Wang, Shan Liu, et al.
Oncotarget|November 21, 2017
GZD824 suppresses the growth of human B cell precursor acute lymphoblastic leukemia cells by inhibiting the SRC kinase and PI3K/AKT pathwaysWei Ye, Zhiwu Jiang, Xiaoyun Lu, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.
Pageof 72

Showing results (691-700 of 716) with videos related to

Sort By:
Pageof 72
Journal of Medicinal Chemistry|June 8, 2026
Structure-Based Design and Optimization of Novel, Potent and Selective Covalent FGFR2/3 Inhibitors with a Tricyclic CoreXuzhi Lu, Zhaodi Tian, Xueqiang Li, et al.
Nature Communications|November 6, 2021
Aerosol-boundary-layer-monsoon interactions amplify semi-direct effect of biomass smoke on low cloud formation in Southeast AsiaKe Ding, Xin Huang, Aijun Ding, et al.
Diabetes|January 22, 2017
Visualization and Quantification of Browning Using a Ucp1-2A-Luciferase Knock-in Mouse ModelLiufeng Mao, Baoming Nie, Tao Nie, et al.
Cancer Science|December 2, 2021
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivoYingqiang Liu, Mengzhen Lai, Shan Li, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|April 3, 2012
Multi-central clinical research into treating 80 cases of chronic thrombocytopenia with qi-supplementing and yin-nourishing therapy and western medicineYu-Hong Zhou, Ke-Ming Wei, Lv-Yuan He, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibitionSanjeev Shangary, Dongguang Qin, Donna McEachern, et al.
Cell Reports. Medicine|March 25, 2026
Targeting the ferritinophagy-lysosome axis as a therapeutic vulnerability in gastroenteropancreatic neuroendocrine tumorsYizhi Cao, Caleb Cheng, Yitong Yin, et al.
Signal Transduction and Targeted Therapy|April 20, 2026
Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trialHong Wang, Qingyuan Wang, Shan Liu, et al.
Oncotarget|November 21, 2017
GZD824 suppresses the growth of human B cell precursor acute lymphoblastic leukemia cells by inhibiting the SRC kinase and PI3K/AKT pathwaysWei Ye, Zhiwu Jiang, Xiaoyun Lu, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.
Pageof 72